Organism name | Lycopodium serratum |
---|---|
Genus | Lycopodium |
Family | Lycopodiaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Huperzia serrata |
---|---|
Linked NCBI taxonomy ID | 355589 |
Linked level | species |
Family in NCBI taxonomy | Lycopodiaceae |
---|---|
ID | 3250 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Embryophyta |
---|---|
ID | 3193 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00028594
![]() |
Miyoshianine B
/ Lycoposerramine J |
![]() |
||||||
C00001653
![]() |
Lycoctonine
/ (+)-Lycoctonine |
CHEMBL517003
CHEMBL1242718 CHEMBL1303310 CHEMBL1975737 CHEMBL2356607 |
C093992
|
3 / 10 / 7 | No. 31 | No. 10 |
![]() |
|
C00028526
![]() |
Lycoposerramine M
|
No. 280 |
![]() |
|||||
C00025380
![]() |
Deacetyllycoclavine
|
No. 280 |
![]() |
|||||
C00001948
![]() |
Lycopodine
|
CHEMBL1738973
|
C016542
|
No. 280 |
![]() |
|||
C00025389
![]() |
Lycodoline
/ Lycopodan-5-one |
No. 280 |
![]() |
|||||
C00028525
![]() |
Lycoposerramine L
|
No. 280 |
![]() |
|||||
C00028524
![]() |
Lycoposerramine K
|
No. 617 |
![]() |
|||||
C00025396
![]() |
Serratidine
|
No. 617 |
![]() |
|||||
C00025387
![]() |
Lucidioline
/ Deacetyldehydrolycoclavine |
No. 617 |
![]() |
|||||
C00028527
![]() |
Lycoposerramine N
|
No. 1101 |
![]() |
|||||
C00001957
![]() |
Serratanidine
|
No. 1185 |
![]() |
|||||
C00001958
![]() |
Serratine
|
No. 1185 |
![]() |
|||||
C00028521
![]() |
Lycoposerramine G
|
No. 1185 |
![]() |
|||||
C00029003
![]() |
Serratinine
|
C009245
|
No. 1185 |
![]() |
||||
C00028826
![]() |
Phlegmariurine A
|
No. 1248 |
![]() |
|||||
C00028520
![]() |
Lycoposerramine E
|
No. 1248 |
![]() |
|||||
C00001941
![]() |
Lucidine B
|
C027890
|
No. 1704 |
![]() |
||||
C00001953
![]() |
Oxolucidine B
|
C029836
|
No. 1704 |
![]() |
||||
C00028530
![]() |
Lycoposerramine Q
|
No. 1709 |
![]() |
|||||
C00038327
![]() |
8alpha,11alpha-Dihydroxyfawcettidine
/ (+)-8alpha,11alpha-Dihydroxyfawcettidine |
No. 1709 |
![]() |
|||||
C00001939
![]() |
Huperzine B
|
CHEMBL183649
CHEMBL245079 |
C053016
|
1 / 1 / 0 | No. 1751 |
![]() |
||
C00001956
![]() |
Selagine
|
No. 2402 |
![]() |
|||||
C00028528
![]() |
Lycoposerramine O
|
No. 2413 |
![]() |
|||||
C00028519
![]() |
Lycoposerramine D
|
No. 2492 |
![]() |
|||||
C00028532
![]() |
Lycoposerramine U
|
No. 2492 |
![]() |
|||||
C00001946
![]() |
Lycoflexine
/ Lycobergine |
No. 2492 |
![]() |
|||||
C00029002
![]() |
Serratinidine
|
No. 2493 |
![]() |
|||||
C00028522
![]() |
Lycoposerramine H
|
CHEMBL229334
|
1 / 1 / 0 | No. 2546 |
![]() |
|||
C00028523
![]() |
Lycoposerramine I
|
No. 2546 |
![]() |
|||||
C00038330
![]() |
8alpha-Hydroxylycothunine
/ (+)-8alpha-Hydroxylycothunine |
No. 2993 |
![]() |
|||||
C00038224
![]() |
2beta-Hydroxylycothunine
|
No. 2993 |
![]() |
|||||
C00028529
![]() |
Lycoposerramine P
|
No. 2993 |
![]() |
|||||
C00028518
![]() |
Lycoposerramine C
|
No. 3565 |
![]() |
|||||
C00028592
![]() |
Miyoshianine A
/ Lycoposerramine F |
No. 4732 |
![]() |
|||||
C00028517
![]() |
Lycoposerramine A
|
No. 5344 |
![]() |
|||||
C00028531
![]() |
Lycoposerramine S
|
No. 5344 |
![]() |
|||||
C00028536
![]() |
Macleanine
|
No. 7329 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P22303 | Acetylcholinesterase | Hydrolase | C00001939 C00028522 | 1 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001653 | 2 / 3 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001653 | 7 / 3 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001653 | 1 / 1 |
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
Q13148
(related)
|